Fleury SA FLRY3
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- BRL 14.53
- Day Range
- BRL 14.42–14.54
- 52-Week Range
- BRL 13.33–18.96
- Bid/Ask
- BRL 14.43 / BRL 14.45
- Market Cap
- BRL 7.87 Bil
- Volume/Avg
- 48,100 / 3.2 Mil
Key Statistics
- Price/Earnings (Normalized)
- 16.55
- Price/Sales
- 1.10
- Dividend Yield (Trailing)
- 4.01%
- Dividend Yield (Forward)
- 1.02%
- Total Yield
- 4.01%
Company Profile
Fleury SA is engaged in the provision of medical services in the diagnostic, treatment, clinical analysis, health management, medical care, orthopedics and ophthalmology areas and offers its digital healthcare platform. The company carries out its activities through customer service units and hospital-based units. Furthermore, the company has a mobile service operation with coverage in municipalities in addition to a digital platform.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Mid Core
- Total Number of Employees
- 27,300
- Website
- https://www.fleury.com.br
Comparables
Valuation
|
Metric
|
FLRY3
|
RDOR3
|
HAPV3
|
|---|---|---|---|
Price/Earnings (Normalized) | 16.55 | 19.88 | 23.68 |
Price/Book Value | 1.58 | 2.46 | 0.55 |
Price/Sales | 1.10 | 1.19 | 0.99 |
Price/Cash Flow | 4.99 | 7.96 | 10.35 |
Price/Earnings
FLRY3
RDOR3
HAPV3
Financial Strength
|
Metric
|
FLRY3
|
RDOR3
|
HAPV3
|
|---|---|---|---|
Quick Ratio | 1.55 | 2.94 | 1.11 |
Current Ratio | 1.66 | 3.03 | 1.23 |
Interest Coverage | 1.79 | 1.64 | 0.62 |
Quick Ratio
FLRY3
RDOR3
HAPV3
Profitability
|
Metric
|
FLRY3
|
RDOR3
|
HAPV3
|
|---|---|---|---|
Return on Assets (Normalized) | 4.64% | −0.08% | 1.14% |
Return on Equity (Normalized) | 11.21% | −0.32% | 1.73% |
Return on Invested Capital (Normalized) | 8.92% | 5.35% | 3.17% |
Return on Assets
FLRY3
RDOR3
HAPV3
Diagnostics & Research Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
TMO
| Thermo Fisher Scientific Inc | Fxsvrmdkz | Kdp | $209.3 Bil | |
DHR
| Danaher Corp | Lsnjjytffk | Mzqlcq | $185.5 Bil | |
IQV
| IQVIA Holdings Inc | Xphymmkh | Qmjvyd | $43.4 Bil | |
IDXX
| IDEXX Laboratories Inc | Ndxqpwnbyy | Fwkrfd | $41.0 Bil | |
A
| Agilent Technologies Inc | Pvgchnxjnt | Zbn | $40.3 Bil | |
MTD
| Mettler-Toledo International Inc | Gxlhtmnh | Txgqjv | $26.4 Bil | |
ICLR
| Icon PLC | Dsbsztpmh | Ftddgvb | $25.2 Bil | |
ILMN
| Illumina Inc | Cbbgcwj | Zzsnwqp | $19.6 Bil | |
WAT
| Waters Corp | Ybgwccnzgk | Ysy | $18.0 Bil | |
LH
| Laboratory Corp of America Holdings | Mpjyxzfpc | Vdcfb | $17.5 Bil |